about
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also con...
Read More
12.49
-1.20
(-8.77%)
50,399
XNAS Volume
XNAS 27 Feb, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Polyrizon Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..